Health Trials

Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane

ConditionPediatric Anesthesia
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age1-36
SponsorBaylor College of Medicine

About this trial

The purpose of this protocol is to determine the effect of two clinically applicable Dexmedetomidine dosages (0.5mcg/kg and 1mcg/kg) on the minimum alveolar concentration (MAC) of Sevoflurane in children between the age ranges of: 1-6 months; 6-12 months of age and 12 months-36 months years of age.

Eligibility criteria

Qualifiers

None

Disqualifiers

Interstitial lung disease, chest wall disease, or bronchospastic disease with no flare-ups in the past 2 weeks of presentation

History of difficult intubation or ventilation

Airway malformation

Congenital heart disease

Trial design

Treatments tested in this trial

  • Dexmedetomidine

Treatment groups

180 Participants
are divided into 9 treatment groups

9

Treatment groups

See each treatment group below.

Sponsors and collaborators

Baylor College of Medicine

Lead sponsor

Source ClinicalTrials.gov